GSDMD and neoplasm: The results showed that in tumor samples, GSDMD expression was positively correlated with the level of CD8+ T-cell markers in The Cancer Genome Atlas (TCGA) cohorts, and that GSDMD was upregulated in activated CD8+ T cells, while its deficiency would reduce the cytolytic ability of CD8+ T cells.